Hospira said U.S. health regulators raised fresh concerns about the injectable-drugs maker's troubled Rocky Mount, N.C., manufacturing plant, one of its largest production facilities.
FDA flags new concerns on Hospira's plant
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content